Diabetes and Cancer

Diabetes and malignant growth are predominant ailments with high effect on wellbeing around the world. Epidemiologic observer proposes that individuals with diabetes are at altogether higher hazard for some types of malignancy. Type 2 diabetes and malignancy share a few hazard factors, however conceivable biologic connections between the two infections are not entirely comprehended. Besides, observer from observational investigations recommends that a few meds used to treat hyperglycemia are connected with either expanded or decreased danger of malignant growth.

 

    Related Conference of Diabetes and Cancer

    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Paris, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    October 27-28, 2025

    5th World Congress on Endocrine and Diabetes

    Madrid, Spain
    October 30-31, 2025

    5th Annual Summit on Diabetes and Endocrinology

    Paris, France
    November 03-04, 2025

    34th European Diabetes Congress

    Rome, Italy
    November 06-07, 2025

    8th Annual Meeting on Diabetes and Endocrinology

    Dubai, UAE
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France
    November 24-25, 2025

    6th International conference on Diabetic complications

    Barcelona, Spain
    February 23-24, 2026

    19th International Summit on Diabetes

    London, UK
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France

    Diabetes and Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in